Cognex Corporation (CGNX) Tops Q1 EPS by 7c; Guides Q2 Revs Above
Tweet
Share
E-mailGet Alerts CGNX Hot Sheet
Price: $62.25 +2.40%
EPS Growth %: +57.6%
Financial Fact:
Foreign currency gain (loss): -607K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +57.6%
Financial Fact:
Foreign currency gain (loss): -607K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cognex Corporation (NASDAQ: CGNX) reported Q1 EPS of $0.32, $0.07 better than the analyst estimate of $0.25. Revenue for the quarter came in at $74.4 million versus the consensus estimate of $71.73 million.
Sees Q2 2011 revenue of $79-$82 million, versus the consensus of $77.4 million.
Sees Q2 2011 revenue of $79-$82 million, versus the consensus of $77.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Torrid Holdings Inc. (CURV) Tops Q2 EPS by 8c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
